<p>Emerald Mutual Fund Advisers Trust 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第三季度削减了其在 Omada Health, Inc.（NASDAQ:OMDA - 免费报告）股票的持有量，减少幅度为 61.6%。该机构投资者在此期间售出了 99,302 股后，持有 61,925 股公司的股票。截至其最近向证券交易委员会（SEC）提交的文件，Emerald Mutual Fund Advisers Trust 持有的 Omada Health 股票约占 0.11%，价值 1,369,000 美元。</p>
<p>其他机构投资者也对该公司的股份进行了增持或减持。Raymond James Financial Inc. 在第二季度购买了价值约 32,000 美元的 Omada Health 新股份。Rakuten Investment Management Inc. 在第三季度购买了价值约 49,000 美元的 Omada Health 新头寸。Ilex Capital Partners UK LLP 在第二季度购买了价值 201,000 美元的 Omada Health 新股份。Wilmington Savings Fund Society FSB 在第三季度购买了价值 287,000 美元的 Omada Health 新股份。最后，Sandia Investment Management LP 在第二季度购买了价值 366,000 美元的 Omada Health 新股份。</p>
<h2>分析师设定新目标价</h2>
<p>几位研究分析师最近对该公司发表了评论。巴克莱将 Omada Health 的目标价从 29.00 美元下调至 22.00 美元，并在 1 月 5 日的研究报告中给予该公司 “增持” 评级。高盛集团重申了对 Omada Health 的 “买入” 评级，并在 1 月 16 日的报告中发布了 26.00 美元的目标价。Needham &amp; Company LLC 在周四重申了 “买入” 评级，并对 Omada Health 发布了 28.00 美元的目标价。富国银行在 1 月 8 日的研究报告中开始覆盖 Omada Health 的股票，给予 “持平” 评级，目标价为 17.00 美元。最后，BMO Capital Markets 在 11 月 13 日的研究报告中开始覆盖 Omada Health 的股票，设定了 “跑赢大盘” 评级和 27.00 美元的目标价。八位投资分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，Omada Health 目前的平均评级为 “适度买入”，共识目标价为 25.10 美元。</p>
<p><strong>查看我们关于 Omada Health 的最新研究报告</strong></p>
<h2>Omada Health 股票表现</h2>
<p>Omada Health 股票在周五开盘价为 16.52 美元。该股票的市值为 9.5667 亿美元，市盈率为 -66.08。该股票的 50 日移动平均线为 16.38 美元，200 日移动平均线为 19.88 美元。Omada Health, Inc. 的一年低点为 14.14 美元，一年高点为 28.40 美元。</p>
<h2>内部交易活动</h2>
<p>在其他 Omada Health 的新闻中，总裁 Wei-Li Shao 于 12 月 29 日星期一出售了 5,618 股公司的股票。该股票以平均价格 16.13 美元出售，总交易额为 90,618.34 美元。出售后，总裁持有 69,079 股公司的股票，价值约 1,114,244.27 美元。此次交易使其持股减少了 7.52%。该交易已在向证券交易委员会提交的文件中披露，相关文件可在此链接查看。此外，首席执行官 Sean P. Duffy 于 1 月 12 日星期一出售了 230,479 股公司的股票。该股票以平均价格 15.60 美元出售，总交易额为 3,595,472.40 美元。交易后，首席执行官持有 126,644 股公司的股票，价值 1,975,646.40 美元。此次交易使其持股减少了 64.54%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售了价值 4,336,787 美元的 276,893 股公司股票。</p>
<h2>Omada Health 公司简介</h2>
<p>（免费报告）</p>
<p>Omada Health 是一家数字健康公司，专注于通过个性化的技术驱动程序预防和管理慢性疾病。该公司的平台结合了数据分析、行为科学和人类辅导，以支持面临风险或患有如前糖尿病、2 型糖尿病、高血压和肌肉骨骼疾病等疾病的个体。参与者通过移动应用程序或网络门户访问该程序，在那里他们可以获得量身定制的课程、健康指标反馈和持续的虚拟辅导。</p>
<p>除了核心的疾病管理服务外，Omada Health 还扩展了其服务，包括心理健康支持和数字治疗以帮助体重管理。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 Omada Health 更好</li>
<li>投资者警报：微小的 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>没有人告诉你的 100 万亿美元的 AI 故事</li>
<li>在周一上午 9:30 买入这只股票！</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>埃隆将 SpaceX 上市！100 美元的 IPO 前机会！</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Omada Health 吗？</h2>
<p>在你考虑 Omada Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 Omada Health 并不在名单上。</p>
<p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得投资。</p>
<p>在这里查看五只股票</p>

美国医疗保健供应商 ETF - iShares

美国医药设备 ETF - iShares

OMDA

标普医疗保健服务 ETF - SPDR

标普健康医疗设备 ETF - SPDR

<p>Emerald Mutual Fund Advisers Trust 在第三季度减少了对 Omada Health, Inc. (NASDAQ:OMDA) 的持股比例，减持了 61.6%，出售了 99,302 股，保留了价值约 137 万美元的 61,925 股。其他机构投资者也调整了他们的持仓。分析师为 Omada Health 设置了新的价格目标，巴克莱将其下调至 22.00 美元，而高盛则维持在 26.00 美元。该股票开盘价为 16.52 美元，市值为 9.5667 亿美元。内部人士的销售包括总裁 Wei-Li Shao 和首席执行官 Sean P. Duffy 的重大交易</p>

<p>Emerald Mutual Fund Advisers Trust trimmed its holdings in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) by 61.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,925 shares of the company's stock after selling 99,302 shares during the period. Emerald Mutual Fund Advisers Trust owned about 0.11% of Omada Health worth $1,369,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Emerald Mutual Fund Advisers Trust 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第三季度削减了其在 Omada Health, Inc.（NASDAQ:OMDA - 免费报告）股票的持有量，减少幅度为 61.6%。该机构投资者在此期间售出了 99,302 股后，持有 61,925 股公司的股票。截至其最近向证券交易委员会（SEC）提交的文件，Emerald Mutual Fund Advisers Trust 持有的 Omada Health 股票约占 0.11%，价值 1,369,000 美元。</p>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $32,000. Rakuten Investment Management Inc. bought a new position in Omada Health in the third quarter worth approximately $49,000. Ilex Capital Partners UK LLP purchased a new stake in Omada Health during the second quarter worth $201,000. Wilmington Savings Fund Society FSB bought a new stake in Omada Health during the 3rd quarter valued at $287,000. Finally, Sandia Investment Management LP bought a new stake in Omada Health during the 2nd quarter valued at $366,000.</p>
<div class="lb-trans"><p>其他机构投资者也对该公司的股份进行了增持或减持。Raymond James Financial Inc. 在第二季度购买了价值约 32,000 美元的 Omada Health 新股份。Rakuten Investment Management Inc. 在第三季度购买了价值约 49,000 美元的 Omada Health 新头寸。Ilex Capital Partners UK LLP 在第二季度购买了价值 201,000 美元的 Omada Health 新股份。Wilmington Savings Fund Society FSB 在第三季度购买了价值 287,000 美元的 Omada Health 新股份。最后，Sandia Investment Management LP 在第二季度购买了价值 366,000 美元的 Omada Health 新股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several research analysts have recently commented on the company. Barclays reduced their price target on Omada Health from $29.00 to $22.00 and set an &#34;overweight&#34; rating for the company in a research report on Monday, January 5th. The Goldman Sachs Group reiterated a &#34;buy&#34; rating and issued a $26.00 target price on shares of Omada Health in a report on Friday, January 16th. Needham &amp; Company LLC restated a &#34;buy&#34; rating and issued a $28.00 price target on shares of Omada Health in a report on Thursday. Wells Fargo &amp; Company began coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an &#34;equal weight&#34; rating and a $17.00 price objective on the stock. Finally, BMO Capital Markets began coverage on shares of Omada Health in a research note on Thursday, November 13th. They set an &#34;outperform&#34; rating and a $27.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Omada Health presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $25.10.</p>
<div class="lb-trans"><p>几位研究分析师最近对该公司发表了评论。巴克莱将 Omada Health 的目标价从 29.00 美元下调至 22.00 美元，并在 1 月 5 日的研究报告中给予该公司 “增持” 评级。高盛集团重申了对 Omada Health 的 “买入” 评级，并在 1 月 16 日的报告中发布了 26.00 美元的目标价。Needham &amp; Company LLC 在周四重申了 “买入” 评级，并对 Omada Health 发布了 28.00 美元的目标价。富国银行在 1 月 8 日的研究报告中开始覆盖 Omada Health 的股票，给予 “持平” 评级，目标价为 17.00 美元。最后，BMO Capital Markets 在 11 月 13 日的研究报告中开始覆盖 Omada Health 的股票，设定了 “跑赢大盘” 评级和 27.00 美元的目标价。八位投资分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，Omada Health 目前的平均评级为 “适度买入”，共识目标价为 25.10 美元。</p>
</div><p><strong>View Our Latest Research Report on Omada Health</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Omada Health 的最新研究报告</strong></p>
</div><h2>Omada Health Stock Performance</h2>
<div class="lb-trans"><h2>Omada Health 股票表现</h2>
</div><p>Omada Health stock opened at $16.52 on Friday. The stock has a market cap of $956.67 million and a PE ratio of -66.08. The stock has a 50-day moving average of $16.38 and a two-hundred day moving average of $19.88. Omada Health, Inc. has a one year low of $14.14 and a one year high of $28.40.</p>
<div class="lb-trans"><p>Omada Health 股票在周五开盘价为 16.52 美元。该股票的市值为 9.5667 亿美元，市盈率为 -66.08。该股票的 50 日移动平均线为 16.38 美元，200 日移动平均线为 19.88 美元。Omada Health, Inc. 的一年低点为 14.14 美元，一年高点为 28.40 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the business's stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $16.13, for a total transaction of $90,618.34. Following the sale, the president owned 69,079 shares of the company's stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CEO Sean P. Duffy sold 230,479 shares of the company's stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $15.60, for a total transaction of $3,595,472.40. Following the transaction, the chief executive officer owned 126,644 shares in the company, valued at $1,975,646.40. The trade was a 64.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 276,893 shares of company stock worth $4,336,787.</p>
<div class="lb-trans"><p>在其他 Omada Health 的新闻中，总裁 Wei-Li Shao 于 12 月 29 日星期一出售了 5,618 股公司的股票。该股票以平均价格 16.13 美元出售，总交易额为 90,618.34 美元。出售后，总裁持有 69,079 股公司的股票，价值约 1,114,244.27 美元。此次交易使其持股减少了 7.52%。该交易已在向证券交易委员会提交的文件中披露，相关文件可在此链接查看。此外，首席执行官 Sean P. Duffy 于 1 月 12 日星期一出售了 230,479 股公司的股票。该股票以平均价格 15.60 美元出售，总交易额为 3,595,472.40 美元。交易后，首席执行官持有 126,644 股公司的股票，价值 1,975,646.40 美元。此次交易使其持股减少了 64.54%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售了价值 4,336,787 美元的 276,893 股公司股票。</p>
</div><h2>Omada Health Company Profile</h2>
<div class="lb-trans"><h2>Omada Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.</p>
<div class="lb-trans"><p>Omada Health 是一家数字健康公司，专注于通过个性化的技术驱动程序预防和管理慢性疾病。该公司的平台结合了数据分析、行为科学和人类辅导，以支持面临风险或患有如前糖尿病、2 型糖尿病、高血压和肌肉骨骼疾病等疾病的个体。参与者通过移动应用程序或网络门户访问该程序，在那里他们可以获得量身定制的课程、健康指标反馈和持续的虚拟辅导。</p>
</div><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p>
<div class="lb-trans"><p>除了核心的疾病管理服务外，Omada Health 还扩展了其服务，包括心理健康支持和数字治疗以帮助体重管理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>Buy This Stock at 9:30 AM on MONDAY!</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Omada Health 更好</li>
<li>投资者警报：微小的 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>没有人告诉你的 100 万亿美元的 AI 故事</li>
<li>在周一上午 9:30 买入这只股票！</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>埃隆将 SpaceX 上市！100 美元的 IPO 前机会！</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=OMDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Omada Health 吗？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Omada Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 Omada Health 并不在名单上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得投资。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看五只股票</p>
</div>

Emerald Mutual Fund Advisers Trust 出售了 99,302 股 Omada Health, Inc. $OMDA